Free Trial!
Today’s Best Stocks To Trade! Click Here
Featured Stock: QED Connect, Inc.
(PinkSheets: QEDC | news | PowerRating | PR Charts ) Current Price (0.14) www.LiquidStockReport.com
QED Connect Wins Contract with Randolph Technical Career Center
QED's Omni Manager Replaces RTCC's Current Internet Filtering Provider
NASHUA, NH - January 10, 2007 - QED Connect, Inc., (otc: QEDC | news | PowerRating | PR Charts ) an innovative software-as-a-service (SaaS) provider for the information security market, today announced that Vermont-based Randolph Technical Career Center (RTCC) has chosen its flagship Omni Manager for Internet security, monitoring and reporting. Omni Manager replaced the current web filtering provider at RTCC, a secondary technical education center in Randolph, VT. The hosted service was implemented on approximately 180 computers in the labs and classrooms to provide Internet filtering, monitoring and reporting.
"We had to replace our current Internet filtering solution because it was causing too many problems and draining a lot of resources, both financial and human," said Bill Sugarman, Principal at RTCC. "Omni Manager was a viable alternative that presented none of those issues. As a hosted application completely maintained by QED, it doesn't burden our network resources or drain IT management time. The reporting feature is especially robust, giving us visibility into where users are going on the Internet, as well as well as their use of music and game downloads other bandwidth-draining applications."
About QED Connect, Inc.
QED Connect, Inc. is an information security Software-as-a-Service (SaaS) provider that gives organizations visibility, management and control of activity on all their computers, laptops and wireless devices. The company's popular SaaS, Omni Manager, is a web-hosted software application completely maintained and operated by QED. Customers do not install any software on their end, yet they obtain the benefits of packaged, commercially licensed software without the complexity and high cost.
Omni Manager is an affordable way to monitor and manage how employees are using company computers and the Internet at any time, from any location in the world This solves the problems created by today's virtual' work environment of branch offices, remote workers and traveling employees. Omni Manager offers all the essential security applications in one subscription-based service, including e-mail and Internet filtering and blocking, antivirus, instant messaging control, asset tracking, application usage monitoring and policy management. ROI is delivered in the form of improved employee productivity, cost savings and operational efficiencies. For more information, visit www.qedconnect.com.
Safe Harbor Statement Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of QED Connect, Inc., (the Company) to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors.
For an in-depth analyst report, please visit: www.LiquidStockReport.com
Dynacq Healthcare Inc.
(Nasdaq:DYII) Current Price (5.00) www.LiquidStockReport.com HOUSTON--Jan 10--Dynacq Healthcare, Inc. (DYII) today reported financial results for its first fiscal quarter. For the fiscal quarter ended November 30, 2007, the Company had income from continuing operations of $0.13 per share compared to a loss from continuing operations of $0.04 per share in the fiscal quarter ended November 30, 2006. All per share amounts are calculated on a fully diluted basis. Dynacq Healthcare, Inc., through its subsidiaries, engages in the development and management of general acute care hospitals primarily in the United States. These hospitals provide specialized general surgeries, such as bariatric, orthopedic, and neuro-spine surgeries. The company also provides fertility, sleep laboratory, and pain management services, as well as minor emergency treatment services; and ear, nose, and throat services. Its hospitals include operating rooms, pre- and post-operative space, intensive care units, nursing units, and diagnostic facilities, as well as adjacent medical office buildings that lease space to physicians and other healthcare providers. Further, Dynacq Healthcare has a 70% equity interest in Shanghai DeAn Hospital, a joint venture for constructing a hospital in Shanghai, China. The company was founded in 1983. It was formerly known as Dynacq International, Inc. and changed its name to Dynacq Healthcare, Inc. in 2003. Dynacq Healthcare is based in Houston, Texas.
WSI Industries, Inc.
(NasdaqCM:WSCI) Current Price (6.45) www.LiquidStockReport.com MINNEAPOLIS--Jan 10--WSI Industries, Inc. (Nasdaq:WSCI - News) today reported sales for its fiscal 2008 first quarter ending November 25, 2007 of $5,975,000, an increase of 45% over the prior year amount of $4,129,000. Net income for the fiscal 2008 first quarter was $387,000 or $.14, an increase of $250,000 over the prior year net income of $137,000 or $.05 per share. Included in the fiscal 2008 first quarter income was a gain on sale of equipment which contributed $98,000 to pre-tax income. WSI Industries, Inc. is a leading contract manufacturer that specializes in the machining of complex, high-precision parts for a wide range of industries, including avionics and aerospace, energy, recreational vehicles, small engines, marine, bioscience and the defense markets.
BioDelivery Sciences International Inc (Nasdaq:BDSI) Current Price (2.89) www.LiquidStockReport.com RALEIGH, N.C.--Jan10-BioDelivery Sciences International, Inc. (Nasdaq:BDSI - News)(http://www.biodeliverysciences.com) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing BDSI's new drug application (NDA) for BEMA Fentanyl that was submitted on October 31, 2007, for the management of breakthrough cancer pain in opioid tolerant patients. The acceptance of the filing means the FDA has made an initial determination that the NDA is sufficiently complete to warrant a substantive review. A final decision by FDA is expected in August 2008. BioDelivery Sciences International, Inc. operates as a specialty biopharmaceutical company in the United States. It uses its licensed and patented drug delivery technologies to develop and commercialize new formulations of proven therapeutics aimed at acute conditions occurring in cancer and surgical patients, such as pain, nausea and vomiting, insomnia, and fungal infections. The company's lead product, BEMA Fentanyl, is in the Phase III clinical trials for the treatment of breakthrough cancer pain. Its products also include BEMA Long Acting Analgesic, a Phase I completed clinical trial product for the treatment of pain conditions, including post operative and, potentially, chronic pain due to osteoarthritis, lower back disorders, and rheumatoid arthritis; BEMA Zolpidem, a preclinical stage product for the treatment of insomnia; and Bioral Amphotercin B, a Phase I clinical trial product for the treatment of fungal infections. The company's product pipeline also includes Bioral formulation, which is an encochleated version of Amphotericin B; and a second formulation for intranasal administration Amphotericin B to treat chronic rhinosinusitis. The company is also developing Emezine, a formulation of prochlorperazine, which is used for the treatment of nausea and vomiting. It has a clinical development and license agreement with Clinical Development Capital, LLC relating to its BEMA Fentanyl product. BioDelivery Sciences International was founded in 1997 and is based in Morrisville, North Carolina.
Stinger Systems, Inc.
(OTC BB:STIY) Current Price (1.52) www.LiquidStockReport.com TAMPA, Fla., Jan. 10 -- Stinger Systems, Inc. (OTC Bulletin Board: STIY - News), a leader in electro-stun technology, today announced that Mr. Matthew McKay's at Jeffries & Co. statement that Taser's challenged 7,234,262 patent only reads upon its low sales volume M-26 weapon is grossly inaccurate. The 7,234,262 patent is for the data recording feature, which is integral to the circuit design of both Taser's M26 and X26 weapons. The X-26 provides the vast bulk of Taser International, Inc.'s weapon sales. Tasers's patent 5,936,183 for a non-lethal landmine has already been cancelled, and the United States Patent Office has refused to reinstate the patent. On December 21, 2007, Stinger Systems, Inc. filed PTO/SB/57 with the U.S. Commissioner of Patents for a reexamination of Taser International, Inc.'s (Nasdaq: TASR - News) intellectual property. With the allegations of inequitable conduct in a pending federal law suit, Taser's related patents 6,636,412 and 7,075,412 are also at risk of invalidation, as well as their wave shaping technology which some consider Taser's core technology. Stinger Systems, Inc., a leading provider of electro stun technologies, develops and sells a broad array of products utilizing advanced electro sparc- pulsed technology to police, corrections, and security sectors worldwide. http://www.stingersystems.com.
Penny Stocks traded in the Small Cap Markets who seek Investor Relations, can receive complete coverage from LiquidStockReport.com. LiquidStockReport.com covers Penny Stock analyst reports and strives to keep the Penny Stock Investor updated. It is essential that the smallcap stock investor stay informed when making decisions through Penny Stock analyst reports. Visitors can sign up for our penny stock newsletter and analyst reports, to be kept up to date when we begin coverage on new small cap companies. Coverage of micro cap stock Companies and Penny Stock analyst reports are provided by LiquidStockReport.com. Sign up today and stay informed of your Investment, allow LiquidStockReport.com to provide you with the latest analyst reports on small cap and pennystocks.
LiquidStockReport.com is owned and operated by Iron Consulting.
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), LiquidStockReport.com is owned and operated by Iron Consulting. Iron Consulting has received thirty five thousand dollars from Equity Alliance Intl. for its internet marketing services, from Equity Alliance Int. LLC www.equityallianceir.com for its marketing and consulting services. Neither Iron Consulting www.ironconsultinginc.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are e made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Market Advisors Inc. The information and opinions in this report were prepared by Market Advisors Inc. (located in Nebraska) who does receive fees for services including preparation of this report. For this report, officers of Market Advisors Inc received $2,500 from a non-affiliated third party. This is not an offer to buy or sell securities nor should this report be construed as investment advise. Information or statements are subject to numerous risks and uncertainties that cause such statements not to prove accurate. Market Advisors, Inc. does not disseminate, nor is it liable for the dissemination by any third party of this information.
CONTACT: LiquidStockReport.com e-mail: ironconsulting@gmail.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
